Diagnosis and Treatment of Smoke Inhalation in Small Animal Patients

Introduction

Smoke inhalation is a potentially life-threatening emergency in dogs and cats, most commonly associated with house fires. Injury can occur even in the absence of external burns, and clinical signs may be delayed. Understanding the pathophysiology of smoke inhalation is critical for diagnosis, timely intervention, and recovery.

Pathophysiology

Clinical signs associated with smoke inhalation are often multifactorial, occurring from a combination of thermal injury, chemical irritation, and systemic toxicity.

• Thermal injury primarily affects the upper airway due to significant heat dissipation prior to reaching the lower airways, and it can result in oropharyngeal and laryngeal edema, mucosal inflammation and ulceration, and airway obstruction secondary to the swelling and/or sloughed tissue. Cats are especially susceptible to delayed upper airway edema, which can progress over 12 to 24 hours following exposure.
• Chemical injury occurs due to the various irritant gases and particulates found in smoke, such as aldehydes, sulfur dioxide, nitrogen oxides, etc. These substances are able to penetrate the lower airways, leading to bronchial inflammation and constriction, impaired mucociliary clearance, alveolar damage, and increased capillary permeability. The fallout from this inflammatory cascade can result in chemical pneumonitis, pulmonary edema, and secondary infections (e.g., bacterial pneumonia).
• Systemic injury occurs due to incomplete combustion producing toxic gases, specifically carbon monoxide (CO) and cyanide, which often contribute most significantly to the morbidity and mortality of smoke inhalation patients.

CO is a colorless, odorless gas with an increased affinity for hemoglobin (Hb) (approximately 200–250 times more than oxygen). When inhaled, CO binds Hb, forming carboxyhemoglobin (COHb) and leading to several significant pathological sequelae:

• Reduced oxygen carrying capacity: Hb that is bound by CO is not able to participate in oxygen transport, effectively causing a functional anemia.
• Left shift of the oxyhemoglobin dissociation curve: CO binding to Hb increases Hb’s affinity for oxygen at the remaining binding sites, which impedes the release of oxygen into the tissues.

• Cellular and mitochondrial dysfunction: In addition to binding Hb, CO also binds to myoglobin and cytochrome oxidase enzymes, disrupting oxidative phosphorylation and further impairing cellular oxygen utilization.
• Systemic Hypoxemia (despite a normal PaO₂): Because the dissolved oxygen remains normal, arterial oxygen tension (PaO₂) may appear normal or adequate despite severe tissue hypoxia.(Dissolved oxygen refers to the free oxygen (O₂) molecules dissolved in plasma and accounts for approximately 2% of blood oxygen, creating the partial pressure (PaO₂). This partial pressure creates the gradient that allows oxygen transfer to take place. The bound oxygen refers to O₂ attached to Hb in red blood cells and accounts for approximately 98% of total oxygen transport. The dissolved oxygen is what drives diffusion gradient of oxygen exchange in tissues, whereas the bound oxygen acts as a large reservoir of oxygen. Bound oxygen is what determines the total oxygen content of the blood. When the partial pressure of oxygen (PaO₂) drops, the dissolved O₂ enters the tissues, causing bound oxygen to release from Hb to replenish the dissolved pool.)

Clinical Presentation

The mechanisms listed above result in global hypoxic injury, with the heart and brain being especially susceptible. Clinical signs can vary depending on the degree and duration of exposure, and they may worsen over time. These include:

• Respiratory signs: tachypnea, dyspnea, coughing, wheezing, or stridor.
• Soot material on the face or within the oral / nasal cavities.
• Cyanosis or abnormal mucous membrane color.
• Altered mentation, weakness, collapse.

Patients may present with minimal clinical signs initially, but then deteriorate within 24–72 hours, due to progressive airway edema or pulmonary injury.

Diagnostics

High index of suspicion and early recognition is key, as clinical signs are often non-specific. Carbon monoxide toxicity should be suspected when there is any history of fire or smoke exposure, especially in enclosed spaces.

• Pulse Oximetry (SpO₂): This value will often be (falsely) normal or nearly normal, despite obvious respiratory signs. This occurs because standard pulse oximeters are unable to differentiate OXYhemoglobin from CARBOXYhemoglobin.
• Blood Gas Analysis: The PaO2 is typically normal. A metabolic acidosis may be observed, due to tissue hypoxia and lactic acidosis.
• Thoracic Radiographs: These can assess for presence of pulmonary edema.
• Co-Oximetry: This is the gold standard for diagnosis. This directly measures the percentage of carboxyhemoglobin in the blood.
  • While specific COHb thresholds associated with clinical severity are not well established in veterinary patients, evaluations above normal are considered abnormal, and any detectable increase in a symptomatic patient is clinically significant.

 

Carboxyhemoglobin Levels and Clinical Effects
COHb Level	Expected Physiologic Effect	Common Clinical Signs in Dogs and Cats
<5% (normal to mild)	None	Asymptomatic
5 – 15%	Reduced O2 delivery	Tachypnea, exercise intolerance, mild lethargy
15 – 30%	Moderate functional anemia and impaired tissue oxygen release	Weakness, tachycardia, altered mentation, vomiting, ataxia
30 – 50%	Severe hypoxia and cellular dysfunction	Marked lethargy, collapse, neurologic deficits, cardiac arrhythmias
>50%	Life-threatening hypoxia	Coma, seizures, cardiovascular instability, potential death
*These COHb thresholds and clinical correlations are extrapolated from experimental and human data; clinical severity in veterinary patients likely varies greatly depending on species, comorbidities, and duration of exposure.

Treatment

Oxygen Therapy

• 100% oxygen supplementation is the most important therapeutic intervention.
• Oxygen competitively displaces CO from Hb, reducing the half-life of COHb from approximately 4–6 hours on room air (21% O₂) to less than one hour on 100% O₂.
• Oxygen can be delivered via oxygen cage, face mask, nasal cannulas, or through mechanical ventilation.
• Hyperbaric oxygen (HBO) therapy will shorten COHb half-life even more significantly than 100% oxygen and may further reduce the delayed neurologic injury (seen in human patients).
  • Use in veterinary is limited due to lack of availability and lack of definitive evidence of benefit in veterinary patients.

Ventilatory Support

• Patients with severe neurologic signs, refractory hypoxemia, or respiratory fatigue may require mechanical ventilation.
• Positive Pressure Ventilation (PPV) improves alveolar oxygen delivery and accelerates CO elimination.

Cardiovascular and Neurologic Monitoring

• Continuous ECG monitoring is recommended, due to risk of myocardial hypoxic injury resulting in arrhythmias.
• Serial neurologic exams are also recommended, as neurologic impairment can be delayed up to 72 hours from the time of exposure.

Supportive Care

• Reduce stress and anxiety to help reduce excessive oxygen consumption.
• Normal temperature and perfusion can be maintained with the assistance of heat support and intravenous fluids.
• Bronchodilators, if concern for bronchoconstriction is present.
• Analgesia and sedation.
• Address other concurrent injuries, such as thermal burns and cyanide toxicity.

Prognosis

Prognosis depends heavily on the duration and severity of exposure, as well as how quickly oxygen therapy is initiated. Patients who receive early, aggressive oxygen support often show rapid clinical improvement. Prolonged exposure, severe neurologic injury, or concurrent cardiopulmonary disease are associated with a more guarded prognosis.

Conclusions

Smoke inhalation is a complex and potentially fatal condition in small animal patients. Early recognition, aggressive supportive care, and vigilant monitoring for delayed complications are essential to optimizing outcomes. Veterinary teams should maintain a high index of suspicion in any patient rescued from a fire environment, even when external injuries appear minimal.

References

1. Hopper K, Powell LL. “Smoke inhalation injury in small animals.” Vet Clin North Am Small Anim Pract. 2013;43(4):861–874.
2. Silverstein DC, Hopper K (eds). Small Animal Critical Care Medicine. 2nd ed. Elsevier; 2015. (Chapters on smoke inhalation and toxic inhalants)
3. Rozanski EA, Rush JE. “Respiratory distress and oxygen therapy.” In: Manual of Canine and Feline Cardiology. 5th ed. Elsevier; 2015.
4. Wingfield WE, Raffe MR. The Veterinary ICU Book. Teton NewMedia; 2002. (Smoke inhalation and toxic gas exposure)
5. Burk RL, Feeney DA. Small Animal Radiology and Ultrasonography. 3rd ed. Saunders; 2003. (Thoracic imaging changes with inhalation injury)
6. Weaver LK. Clinical practice. “Carbon monoxide poisoning.” N Engl J Med. 2009;360:1217–1225.
7. Hampson NB, Piantadosi CA, Thom SR, Weaver LK. “Practice recommendations in the diagnosis, management, and prevention of carbon monoxide poisoning.” Am J Respir Crit Care Med. 2012;186:1095–1101.
8. Prockop LD, Chichkova RI. “Carbon monoxide intoxication: an updated review.” J Neurol Sci. 2007;262:122–130.